GlassScriptPhysician profile
Stephen W Davies
NPI 1093030314
$8,911.88
in general payments reported to CMS, 2019-2025
32 companies · $1,068 in 2025
The $1,068 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,527 · 2020: $1,257 · 2021: $909 · 2022: $700 · 2023: $1,529 · 2024: $1,922 · 2025: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,798 · Travel and Lodging: $1,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,798.20 |
| Travel and Lodging | $1,720.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,569.54 | 2020-2025 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,506.27 | 2019-2024 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $1,158.74 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $712.64 | 2021-2025 | Watchman Flx, Watchman Access System |
| Abiomed | $486.66 | 2020-2025 | Impella |
| Medtronic Vascular, INC. | $283.21 | 2019-2020 | |
| Hemosonics LLC | $245.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $244.59 | 2019-2025 | Farxiga, Wainua |
| Baxter Healthcare | $169.85 | 2022-2024 | Renal - Acute |
| Merck Sharp & Dohme LLC | $164.35 | 2022-2025 | Verquvo, Keytruda, Recarbrio |
| Amgen INC. | $146.67 | 2025 | Repatha, Repatha |
| Ethicon US, LLC | $144.67 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.24 | 2022-2025 | Lifevest |
| Irhythm Technologies, INC. | $109.05 | 2024 | Zio Monitor, Zio Xt Patch |
| La Jolla Pharmaceutical Company | $105.45 | 2023-2025 | Giapreza |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $99.88 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $96.74 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $81.01 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.24 | 2022-2024 | Jardiance |
| Cvrx, INC. | $54.86 | 2022-2025 | Barostim Neo System |
| Medtronic, INC. | $53.39 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.28 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $30.44 | 2023 | Camzyos |
| Daiichi Sankyo INC. | $29.09 | 2023 | Injectafer |
| Haemonetics Corporation | $28.52 | 2025 | Teg6s Hemostasis System |
| Angiodynamics, INC. | $24.28 | 2025 | Angiovac |
| Getinge USA Sales, LLC | $23.79 | 2024 | Vasoview Hemopro 2 |
| Bolton Medical INC | $22.59 | 2022 | |
| Celgene Corporation | $20.53 | 2024 | Camzyos |
| Bridgebio Pharma, INC. | $14.80 | 2025 | Attruby |
| Chiesi USA, INC. | $13.99 | 2022 | |
| Lilly USA, LLC | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.